DrugBank ID: db11850
DrugCentral: ublituximab
Synonymous : None

Drug Sentece Context

Table 1. Analysis of context sentence of ublituximab gene in 1 abstracts.

pmid sentence
33459118 *Note added in proof on key events announced during December 1-21, 2020: margetuximab-cmkb and ansuvimab-zykl were approved by FDA on December 16 and 21, 2020, respectively; biologics license applications were submitted for ublituximab and amivantamab.